Your browser doesn't support javascript.
loading
High-resolution crystal structures of factor XIa coagulation factor in complex with nonbasic high-affinity synthetic inhibitors.
Fradera, Xavier; Kazemier, Bert; Carswell, Emma; Cooke, Andrew; Oubrie, Arthur; Hamilton, William; Dempster, Maureen; Krapp, Stephan; Nagel, Susanna; Jestel, Anja.
Affiliation
  • Fradera X; Merck Research Laboratories, MSD, Newhouse, Lanarkshire ML1 5SH, Scotland. xavier.fradera@merck.com
Article in En | MEDLINE | ID: mdl-22505407
ABSTRACT
Factor XI (FXI) is a key enzyme in the coagulation pathway and an attractive target for the development of anticoagulant drugs. A small number of high-resolution crystal structures of FXIa in complex with small synthetic inhibitors have been published to date. All of these ligands have a basic P1 group and bind exclusively in the nonprime side of the active site of FXIa. Here, two structures of FXIa in complex with nonbasic inhibitors that occupy both the prime and nonprime sides of the active site are presented. These new structures could be valuable in the design and optimization of new FXIa synthethic inhibitors.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor XIa / Enzyme Inhibitors / Protein Interaction Domains and Motifs Type of study: Prognostic_studies Limits: Humans Language: En Journal: Acta Crystallogr Sect F Struct Biol Cryst Commun Year: 2012 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor XIa / Enzyme Inhibitors / Protein Interaction Domains and Motifs Type of study: Prognostic_studies Limits: Humans Language: En Journal: Acta Crystallogr Sect F Struct Biol Cryst Commun Year: 2012 Type: Article Affiliation country: United kingdom